Clinical Trials Logo

Filter by:
NCT ID: NCT06172556 Completed - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Early Brain Damage Assessment in Aneurysmal Subarachnoid Haemorrhage in Predicting Cognitive Impairment

Start date: January 1, 2021
Phase:
Study type: Observational

the goal of this type of study : observation study is to learn about cerebral edema and hematoma in aneurysmal subarachnoid hemorrhage the main questions it aims to answer are current clinical practices lack predictive models to identify early structural brain abnormalities affecting cognition.

NCT ID: NCT06172049 Completed - Colorectal Cancer Clinical Trials

Incidence of Colorectal Cancer in Southwest China: Based on SCC Database

Start date: January 1, 2014
Phase:
Study type: Observational

To evaluate recent trends in CRC incidence, treatment, and survival in the Southwest China.

NCT ID: NCT06170424 Completed - Morality Clinical Trials

Retrospective Analysis of Spray Skin Treats for Severe Burns

Start date: January 1, 2012
Phase:
Study type: Observational

This study investigated the efficacy of novel approach spray skin for extensive severe burns treatment.

NCT ID: NCT06169995 Completed - Clinical trials for Sedation in the Upper Gastrointestinal Endoscopy

A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

Start date: December 11, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for sedation in Upper Gastrointestinal Endoscopy

NCT ID: NCT06169930 Completed - Survivorship Clinical Trials

Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy

OSmodel
Start date: December 1, 2023
Phase:
Study type: Observational

In this retrospective study, we analyzed data from the Sichuan Cancer Hospital & Institute Esophageal Cancer Case Management Database (SCH-ECCM Database) from January 2010 to December 2017. Our study focused on examining the clinicopathological characteristics, lymph node removal at each station, and treatment details of patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy. Using this data, we developed a prediction model for OS by considering a combination of clinical characteristics and details of lymphadenectomy variables.

NCT ID: NCT06169475 Completed - Septic Shock Clinical Trials

Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Some researchers proposed that the dysregulated response or organ dysfunction can be lessened by reducing the stress response, which further reduce complication and mortality rates of sepsis. Dexmedetomidine is alpha adrenergic receptor agonist, presenting sympatholytic action in certain parts of the brain with anxiolytic, sedative, and pain killing effects. In the experiments of sepsis animal model, dexmedetomidine have been proved to improve serum lactate clearance and the microcirculation. Dexmedetomidine may inhibit inflammation, as it enhances the activity of the immune system while reducing its systemic reaction and lowering cytokine concentrations. There are also evidences in clinical trials with definite safety that dexmedetomidine reduced inflammation, reduced vasopressor requirements and improved organ function. The beta antagonist esmolol has been proposed as a therapy to lower heart rate, thereby improving diastolic filling time, and improving cardiac output, resulting in a reduction in vasopressor support. A recent meta-analysis of 8 randomized studies using esmolol suggested that the 32% risk ratio decreased 28-day mortality, and a meta-analysis of 7 studies using esmolol in patients with sepsis and septic shock was associated with 32% lower 28-day mortality. However, the effect of anti-stress drugs on cerebral hemodynamics is unknown. In this study, investigators are going to apply the technique of transcranial Doppler to assess the reaction of cerebral blood flow in anti-stress group and control group.

NCT ID: NCT06169085 Completed - Elder Clinical Trials

Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants

Start date: August 24, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and PK of Leritrelvir in elder participants

NCT ID: NCT06168929 Completed - Hyperuricemia Clinical Trials

Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects

Start date: December 13, 2023
Phase: Phase 1
Study type: Interventional

The study is being conducted to evaluate the pharmacokinetic, and safety of two sizes of SHR4640 tablets in healthy adults, to explore the bioequivalence between two sizes of SHR4640 tablets.

NCT ID: NCT06168227 Completed - Breast Cancer Clinical Trials

A Multicenter and Real-world Analysis of RC48-ADC in Patients With HER2-positive or HER2-low Expressing, Locally Advanced or Metastatic Breast Cancer

Start date: October 1, 2021
Phase:
Study type: Observational

Evaluate the efficacy and safety of Disitamb Vedotin in patients with HER2-positive or HER2-low expressing, locally advanced or metastatic breast cancer

NCT ID: NCT06167889 Completed - Aging Clinical Trials

A Study of Gender-specific Impact Factors on Elderly Disability and Cognitive Impairment

Start date: January 1, 2009
Phase:
Study type: Observational

Elderly disability and cognitive impairment rates were different between elderly man and woman. Sex-specific risk factors and observed gender differences across the lifespan were associated with different degrees of cognitive and activity of daily living function decline between men and women. However, some of these viewpoint remains controversial. The aim of this study is to explore the gender differences and influencing factors of disability and cognitive impairment among the elderly.